Should we be concerned about thyroid cancer in patients taking glucagon-like peptide 1 receptor agonists?

被引:5
作者
Kannan, Subramanian [1 ]
Nasr, Christian [2 ,3 ]
机构
[1] Narayana Hlth City, Bangaluru, Karnataka, India
[2] Cleveland Clin, Endocrinol Fellowship Program, Cleveland, OH USA
[3] Cleveland Clin, Thyroid Ctr, Cleveland, OH USA
关键词
GLP-1; RECEPTOR; PANCREATITIS; LIRAGLUTIDE; EXPRESSION; BENEFITS; TUMORS;
D O I
10.3949/ccjm.81a.13066
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:142 / 144
页数:3
相关论文
共 14 条
[1]   A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer [J].
Alves, Carlos ;
Batel-Marques, Francisco ;
Macedo, Ana F. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 98 (02) :271-284
[2]   Thyroid Cancer Incidence Patterns in the United States by Histologic Type, 1992-2006 [J].
Aschebrook-Kilfoy, Briseis ;
Ward, Mary H. ;
Sabra, Mona M. ;
Devesa, Susan S. .
THYROID, 2011, 21 (02) :125-134
[3]   The Safety of Incretin-Based Therapies-Review of the Scientific Evidence [J].
Drucker, Daniel J. ;
Sherman, Steven I. ;
Bergenstal, Richard M. ;
Buse, John B. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (07) :2027-2031
[4]   Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies [J].
Elashoff, Michael ;
Matveyenko, Aleksey V. ;
Gier, Belinda ;
Elashoff, Robert ;
Butler, Peter C. .
GASTROENTEROLOGY, 2011, 141 (01) :150-156
[5]   ACTIVATION OF G-PROTEIN-COUPLED RECEPTORS AND THYROID MALIGNANT TUMORS: THE JURY IS STILL OUT [J].
Gagel, Robert F. .
ENDOCRINE PRACTICE, 2011, 17 (06) :957-959
[6]   Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland [J].
Gier, Belinda ;
Butler, Peter C. ;
Lai, Chi K. ;
Kirakossian, David ;
DeNicola, Matthew M. ;
Yeh, Michael W. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (01) :121-131
[7]   GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide [J].
Hegedus, Laszlo ;
Moses, Alan C. ;
Zdravkovic, Milan ;
Tu Le Thi ;
Daniels, Gilbert H. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03) :853-860
[8]   Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation [J].
Knudsen, Lotte Bjerre ;
Madsen, Lars Wichmann ;
Andersen, Soren ;
Almholt, Kasper ;
de Boer, Anne S. ;
Drucker, Daniel J. ;
Gotfredsen, Carsten ;
Egerod, Frederikke Lihme ;
Hegelund, Anne Charlotte ;
Jacobsen, Helene ;
Jacobsen, Soren Dyring ;
Moses, Alan C. ;
Molck, Anne-Marie ;
Nielsen, Henriette S. ;
Nowak, Jette ;
Solberg, Helene ;
Thi, Tu D. L. ;
Zdravkovic, Milan .
ENDOCRINOLOGY, 2010, 151 (04) :1473-1486
[9]   GLP-1 receptor expression in human tumors and human normal tissues:: Potential for in vivo targeting [J].
Koerner, Meike ;
Stoeckli, Martin ;
Waser, Beatrice ;
Reubi, Jean Claude .
JOURNAL OF NUCLEAR MEDICINE, 2007, 48 (05) :736-743
[10]   GLP-1 Receptor Agonists and the Thyroid: C-Cell Effects in Mice Are Mediated via the GLP-1 Receptor and not Associated with RET Activation [J].
Madsen, Lars Wichmann ;
Knauf, Jeffrey A. ;
Gotfredsen, Carsten ;
Pilling, Andrew ;
Sjogren, Ingrid ;
Andersen, Soren ;
Andersen, Lene ;
de Boer, Anne Sietske ;
Manova, Katia ;
Barlas, Afsar ;
Vundavalli, Sushil ;
Nyborg, Niels C. Berg ;
Knudsen, Lotte Bjerre ;
Moelck, Anne Marie ;
Fagin, James A. .
ENDOCRINOLOGY, 2012, 153 (03) :1538-1547